Background Both HMG-CoA reductase inhibitors and ยฎbric acid derivates are used for the treatment of dyslipidemia in Type 2 diabetes patients. The aim of this study was to compare the lipid lowering effect of 40 mg pravastatin, a HMG-CoA reductase inhibitor, and 400 mg bezaยฎbrate, a ยฎbric acid deriva
Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies
โ Scribed by Bernd Franke; Tamara S. Galloway; Terry J. Wilkin
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 342 KB
- Volume
- 21
- Category
- Article
- ISSN
- 1520-7552
- DOI
- 10.1002/dmrr.554
No coin nor oath required. For personal study only.
โฆ Synopsis
The prodromal phase of type 1 diabetes is characterised by the appearance of multiple islet-cell related autoantibodies (Aab). The major target antigens are islet-cell antigen, glutamic acid decarboxylase (GAD), protein-tyrosine phosphatase-2 (IA-2) and insulin. Insulin autoantibodies (IAA), in contrast to the other autoimmune markers, are the only ฮฒ-cell specific antibodies. There is general consensus that the presence of multiple Aab (โฅ 3) is associated with a high risk of developing diabetes, where the presence of a single islet-cell-related Aab has usually a low predictive value. The most commonly used assay format for the detection of Aab to GAD, IA-2 and insulin is the fluid-phase radiobinding assay. The RBA does not identify or measure Aab, but merely detects its presence. However, on the basis of molecular studies, disease-specific constructs of GAD and IA-2 have been employed leading to somewhat improved sensitivity and specificity of the RBA. Serological studies have shown epitope restriction of IAA that can differentiate diabetes-related from unrelated IAA, but current assays do not distinguish between disease-predictive and non-predictive IAA or between IAA and insulin antibodies (IA). More recently, phage display technology has been successful in identifying disease-specific anti-idiotopes of insulin. In addition, phage display has facilitated the in vitro production of antibodies with high affinity. Identification of disease-specific anti-idiotopes of insulin should enable the production of a high affinity reagent against the same anti-idiotope. Such a development would form the basis of a disease-specific radioimmunoassay able to identify and measure particular idiotypes, rather than merely detect and titrate IAA.
๐ SIMILAR VOLUMES
Factors associated with residual insulin secretion and spontaneous remission in Type 1 diabetic patients are important in the evaluation of treatment aimed at modifying the natural history of Type 1 DM. We investigated the effect of parameters at onset on residual beta cell function in 215 Type 1 DM
## Abstract ## Background Islet cell antibodies (ICA) represent a heterogenous group of autoantibodies to diabetesโassociated antigens, including glutamic acid decarboxylase (GAD) and the IAโ2 protein. The objectives of the present study were to compare the prevalence of autoantibodies to known bi
Vascular compression of cranial nerves adjacent to the brain stem has been implicated in a wide variety of disorders affecting their function. The considerable conflicts in published results relate primarily to flaws in study design. The design required of an adequate study is defined and a techniqu